Ratings Mauna Kea Technologies




Real-time Euronext Paris 12:19:49 22/07/2024 BST 5-day change 1st Jan Change
0.42 EUR +5.93% Intraday chart for Mauna Kea Technologies +8.39% -10.83%


  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.


  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.


  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Low profitability weakens the company.
  • One of the major weak points of the company is its financial situation.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last few months, analysts have been revising downwards their earnings forecast.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
-10.83% 27.9M -
-37.79% 14.29B
-52.93% 2.32B
+10.35% 1.76B -
-10.92% 1.48B -
+40.84% 1.39B
-25.49% 856M -
+8.62% 834M -
-37.42% 714M -
-30.73% 580M
Investor Rating
Trading Rating
ESG Refinitiv


Sales growth
Earnings Growth
EBITDA / Sales


P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow


1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision


Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. ALMKT Stock
  4. Ratings Mauna Kea Technologies